Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors

Summary

This clinical trial tests how well a virtual mindfulness and weight management program to mitigate risk of relapse and improve well being for obese cancer survivors in community practice and rural areas. Obesity has been linked to increased risk for certain kinds of cancer and is the second highest modifiable risk factor for cancer. It is also well documented that having a cancer diagnosis and treatment is a stressful experience. It is hoped that an addition of a 10-minute mindfulness-based stress reduction exercise to the virtual positive health habits group focused on weight management can improve wellbeing and distress. Virtual care options continue to extend the reach of medical providers to cancer survivors, particularly those in the rural setting. A virtual behavioral weight management program with an integrated mindfulness component may improve mood, coping strategies, stress management, and weight loss among community practice and rural obese cancer survivors.

Conditions

• Hematopoietic and Lymphoid System Neoplasm
• Malignant Solid Neoplasm
• Obesity-Related Malignant Neoplasm

Interventions

BEHAVIORAL

Behavioral Dietary Intervention

Participate in weight management program

OTHER

Educational Intervention

Receive patient education handouts

OTHER

Health Promotion and Education

View behavioral educational PowerPoint presentation

OTHER

Internet-Based Intervention

Complete virtual behavioral weight management with an integrated mindfulness component program

OTHER

Interview

Ancillary studies

OTHER

Medical Device Usage and Evaluation

Wear Fitbit

BEHAVIORAL

Mindfulness Relaxation

Complete mindfulness components

OTHER

Physical Performance Testing

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

• Mayo Clinic

  lead OTHER

Principal Investigators

• Lisa Howell, Ph.D. · Mayo Clinic Health System-Franciscan Healthcare

Study Design

Allocation

NA

Purpose

PREVENTION

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-09-08

Primary Completion

2024-01-02

Completion

2024-01-02

Countries

• United States

Study Locations